logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
G

Gian Paolo Fadini

Department of Medicine

78H指数
512论文数
2.1W被引数
收录论文 319
发表时间
logo
Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative database意大利儿童1型糖尿病发病率增加及其临床负担：来自大型行政数据库的见解
errActa Diabetologica
IF2.9
err2026-08-21
err0
errOAAI
errEnza Mozzillo; Clara Trimarchi; Raffaella Buzzetti; Riccardo Candido; Valentino Cherubini; Basilio Pintaudi; Luca Degli Esposti; Melania Leogrande; Valentina Perrone; Chiara Capodaglio; Georgia Fousteri; Gian Paolo Fadini
err分享
err收藏
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus定义SGLT2抑制剂和GLP-1受体激动剂在伴有或不伴有超重/肥胖的2型糖尿病成人慢性肾脏病管理中的角色：一项国际德尔菲共识
errAdvances in Therapy
IF4
err2026-05-30
err0
errOAAI
errYehuda Handelsman; Alice Y. Y. Cheng; Gian Paolo Fadini; Pam Kushner; Fabrice Bonnet; Paola Fioretto; Takashi Kadowaki; Naresh Kanumilli; Xavier Cos; Thomas Frese; Linong Ji; Peter Rossing
err分享
err收藏
Change in Effectiveness and Safety Parameters After Initiation of SGLT2 Inhibitors for Post-Transplant Diabetes Mellitus: A Real-World Observational Study移植后糖尿病使用SGLT2抑制剂后有效性和安全性参数的变化：一项真实世界观察性研究
errDiabetes Therapy
IF2.6
err2026-05-30
err0
errOAAI
errMaria Cristina Crepaldi; Monica Vedovato; Mario Luca Morieri; Giovanni Basso; Lucia Federica Stefanelli; Marianna Alessi; Paola Fioretto; Gian Paolo Fadini
err分享
err收藏
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability口服司美格鲁肽暴露量与血糖反应、体重减轻和胃肠道耐受性具有特定关系
errdiabetes, obesity and metabolism
IF0
err2026-05-10
err0
errOAAI
errGian Paolo Fadini; Mario Luca Morieri; Carlotta Boscaro; Benedetta Maria Bonora; Andrea Cignarella
err分享
err收藏
Extracellular vesicles as novel mediators of pathology in Anderson-Fabry disease外泌体作为Anderson-Fabry病病理学的新型介导因子
errClinical Science
IF7.7
err2026-05-01
err0
PREAI
errKalmykova, Anna Olena; Massimino, Maria Lina; Vettore, Monica; Gugelmo, Giorgia; Carraro, Gianni; De Michieli, Laura; Fadini, Gian Paolo; Bertoli, Alessandro; Vitturi, Nicola; Lenzini, Livia
err分享
err收藏
Rethinking diabetes as a modifier of the weight-loss response to incretin-based therapies. A twin trial meta-regression重新思考糖尿病作为肠促胰岛素基 therapies 体重减轻反应的修饰因素。双生子试验元回归分析
errnutrition, metabolism and cardiovascular diseases
IF0
err2026-03-20
err0
PREAI
errMarella Marassi; Riccardo Maria Pollis; Gian Paolo Fadini
err分享
err收藏
Clonal Haematopoiesis in Type 2 Diabetes: A Review of Mechanistic Links With Inflammation and Cardiovascular Disease2型糖尿病中的克隆性造血：炎症和心血管疾病机制联系的综述
errDiabetes/Metabolism Research and Reviews
IF0
err2026-02-10
err0
errOAAI
errLudovica Migliozzi; Marella Marassi; Mattia Albiero; Gian Paolo Fadini
err分享
err收藏
Dapagliflozin in CKD Patients with Fabry Disease达格列净在法布里病合并慢性肾脏疾病患者中的应用
errKidney International Reports
IF5.7
err2025-12-23
err0
errOAAI
errYuri Battaglia; Nicola Vitturi; Giacomo Marchi; Federica Baciga; Federica Caccia; Giorgia Gugelmo; Loris Martinetti; Lucia Federica Stefanelli; Sara Torresani; Antonio Pisani; Eleonora Riccio; Pasquale Esposito; Francesca Viazzi; Cristina Chimenti; Francesca Katiana Martino; Livia Lenzini; Annalisa Sechi; Luca Zanoli; Domenico Girelli; Gian Paolo Fadini
err分享
err收藏
Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus每周一次胰岛素给药在2型糖尿病真实世界管理中的应用。一项类德尔菲共识
errActa Diabetologica
IF2.9
err2025-12-03
err0
errOAAI
errRiccardo Candido; Raffaella Buzzetti; Agostino Consoli; Concetta Irace; Enrico Torre; Roberto Trevisan; Gian Paolo Fadini
err分享
err收藏
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods基于GLP-1RA的心血管获益分层：一项采用AI驱动方法的多源分析，结合患者水平CVOT和真实世界数据
errCardiovascular Diabetology
IF10.6
err2025-10-18
err0
errOAAI
errMario Luca Morieri; Enrico Longato; Veronica Sciannameo; Emily Donatiello; Paola Berchialla; Angelo Avogaro; Agostino Consoli; Gian Paolo Fadini
err分享
err收藏
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational studyGLP-1受体激动剂启动后2型糖尿病缓解：一项观察性研究中使用多种定义评估其频率、特征和结局
errThe Lancet Regional Health - Europe
IF0
err2025-10-15
err0
errOAAI
errGian Paolo Fadini; Andrea Giaccari; Fabio Broglio; Laura Nollino; Bruno Fattor; Roberto Anichini; Giancarla Meregalli; Angelo Avogaro; Agostino Consoli
err分享
err收藏
No evidence that tirzepatide can worsen diabetic retinopathy无证据表明tirzepatide会加重糖尿病视网膜病变
errDiabetologia
IF10.2
err2025-10-06
err0
PREAI
errGian Paolo Fadini
err分享
err收藏
Exploring exosome-mediated effects on renal pathology in Anderson Fabry disease探索外泌体介导的效应在Anderson Fabry疾病中的肾脏病理学作用
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errLenzini, Livia; Massimino, Maria Lina; Vettore, Monica; Iori, Elisabetta; Kalmykova, Anna Olena; Annesi, Giulia; Gugelmo, Giorgia; Carraro, Gianni; Bertoli, Alessandro; Nalesso, Federico; Fadini, Gian Paolo; Vitturi, Nicola
err分享
err收藏
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data口服司美格鲁肽相对于恩格列净在2型糖尿病管理中的有效性。基于真实世界数据的PIONEER-2试验模拟研究
errDiabetes, Obesity and Metabolism
IF0
err2025-09-24
err0
errOAAI
errGian Paolo Fadini MD; Enrico Longato PhD; Sara Poletto ME; Andrea Giaccari MD; Mariangela Ghiani MD; Marco Strazzabosco MD; Maddalena Trombetta MD; Giuseppe Penno MD; Angelo Avogaro MD; Anna Solini MD; Agostino Consoli MD; GLIMPLES study investigators and DARWIN-Renal study investigators
err分享
err收藏
Can Dual Incretin Receptor Agonists Exert Better Cardiovascular Protection than Selective GLP-1 Receptor Agonists? Highlights from SURPASS-CVOT双 incretin 受体激动剂能否比选择性 GLP-1 受体激动剂提供更好的心血管保护？——SURPASS-CVOT 要点
errDiabetes Therapy
IF2.6
err2025-08-31
err0
errOAAI
errGian Paolo Fadini
err分享
err收藏
Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study2型糖尿病患者对GLP-1RA的体重反应的性别差异。一项长期纵向真实世界研究
errPharmacological Research
IF10.5
err2025-07-22
err0
errOAAI
errMarella Marassi; Andrea Cignarella; Giuseppina T. Russo; Laura Nollino; Marco Strazzabosco; Paolo Marzullo; Frida Leonetti; Angelo Avogaro; Agostino Consoli; Gian Paolo Fadini
err分享
err收藏
Incretins and the cardiovascular system: bridging digestion with metabolism胰高血糖素样肽-1（Incretins）与心血管系统：连接消化与代谢
errThe Lancet Diabetes & Endocrinology
IF0
err2025-07-07
err0
PREAI
errAngelo Avogaro; Gian Paolo Fadini
err分享
err收藏
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease与比较药物相比，SGLT-2抑制剂在2型糖尿病合并慢性肾脏病患者中的长期肾脏功能保护作用
errdiabetes obesity metabolism
IF0
err2025-07-02
err0
errOAAI
errGian Paolo Fadini MD; Enrico Longato MD; Mario Luca Morieri MD; Fabio Broglio MD; Gianluca Aimaretti MD; Giuseppina T. Russo MD; Roberto Anichini MD
err分享
err收藏
The Clock is Still Ticking: Tirzepatide and the Myth of Halting the Natural History of Type 2 Diabetes时钟仍在滴答作响：Tirzepatide与阻止2型糖尿病自然史发展的神话
errDiabetes Therapy
IF2.6
err2025-06-17
err0
errOAAI
errGian Paolo Fadini
err分享
err收藏
The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes糖尿病肾并发症中，临床病史对机器学习及深度学习模型预测性能的影响
errCOMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
IF4.8
err2025-06-05
err0
PREAI
errDei Cas, Davide; Di Camillo, Barbara; Fadini, Gian Paolo; Sparacino, Giovanni; Longato, Enrico
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
R
Roxana Mehran
H 指数: 172 · 论文数: 2.6K
S
Stefanie Dimmeler
H 指数: 164 · 论文数: 924
A
Andreas M. Zeiher
H 指数: 164 · 论文数: 1.0K
S
Stephen R. Quake
H 指数: 145 · 论文数: 694
C
Carlos A. Camargo
H 指数: 144 · 论文数: 2.0K
查看更多